Darholding Ltd Reports Portfolio Company Growth for 2016

Tuesday, June 13, 2017 General News
Email Print This Page Comment
Font : A-A+

BUDAPEST, Hungary, June 13, 2017 /PRNewswire/ --

DARHOLDING, the largest upstream Holding of corporations in

Central Europe has closed an excellent year in 2016. The portfolio companies have achieved great results in biotechnology, flow chemistry, nano- and space technology. THALESNANO (http://www.thalesnano.com), the global leader of flow chemistry
released its new H Cube Mini + benchtop hydrogenation unit, that aims to bring flow hydrogenation even further into the chemistry mainstream. It also won a EUR 4 million EU grant for its development projects. COMINNEX (http://www.cominnex.com) the unique chemistry CRO for pharmaceutical early stage research has grown its revenue 30% from last year, securing multi-year contracts with major pharma companies while multiplying its EBITDA. INNOSTUDIO (http://www.innostudio.org) and COMZAT put a foothold on space technology by presenting its concepts and results at the very first symposium organized on Space Chemistry which was organized by the American Chemical Society. AROMAX (http://www.aromax.hu) completed its 2 years reorganization period, and produced a 20% growth in sales revenue with a substantial increase in EBITDA. AGROTHETIS (http://www.agrothetis.com) enlarged its portfolio while some of its nanoized agrochem active ingredients entered into the open field assay phase. DRUGGABILITY TECHNOLOGIES (http://www.drgtco.com) successfully closed two human clinical investigations on its nanoized pharmaceutical active ingredients. NUFORMIX, (http://www.nuformix.com), a Cambridge based company with an unique technology for forming co-crystals for APIs is getting closer of being acquired by the UK stock listed Levrett Plc (http://www.levrett.com; LVRT)  in a transaction that was announced in September 2016 (http://levrett.com/wp-content/uploads/Levrett-RNS-160916-v2.pdf )

Contact: news@darholding.com 

SOURCE Darholding Ltd



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook